Related Experiment Videos
Management of meningococcemia
Jasjit Singh1, Antonio C Arrieta
1Division of Pediatric Infectious Diseases, Children's Hospital of Orange County, 455 South Main Street, Orange, CA 92868, USA. jsingh@choc.org
Indian Journal of Pediatrics
|November 9, 2004
Summary
Meningococcemia, a severe disease, leads to significant illness and death globally. This review covers its causes, symptoms, treatments, and prevention, including genetic factors and new vaccines.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Meningococcemia is a severe bacterial infection with high global morbidity and mortality.
- It often presents as fulminant disease, requiring urgent medical attention.
- Understanding its epidemiology and pathogenesis is crucial for effective control.
Purpose of the Study:
- To provide a comprehensive review of meningococcemia.
- To discuss recent advances in understanding genetic predispositions.
- To update on novel therapeutic strategies and vaccine development.
Main Methods:
- Literature review of background, pathophysiology, and clinical manifestations.
- Analysis of current treatment modalities, including adjunctive therapies.
- Evaluation of prevention strategies, focusing on conjugate vaccines and public health aspects.
Main Results:
- Meningococcemia presents with diverse clinical manifestations and pathophysiology.
- Genetic factors play a role in susceptibility to invasive meningococcal disease.
- Monoclonal antibodies and activated protein C show potential as adjunctive treatments.
- Conjugate vaccines are advancing in development and implementation.
Conclusions:
- Effective management of meningococcemia requires a multifaceted approach.
- Continued research into genetic susceptibility and novel therapies is essential.
- Vaccine development and public health initiatives are key to reducing disease burden.